Related Experiment Videos
Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase
1Duke University Medical Center, Durham, North Carolina 27707.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.
Clinical pharmacology and therapeutics·2015
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.
Clinical pharmacology and therapeutics·2012
A novel mutation in purine nucleoside phosphorylase in a child with normal uric acid levels.
Clinical biochemistry·2009
Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency.
Journal of immunology (Baltimore, Md. : 1950)·2001
Selection transduction defect (STD) due to Zap-70 kinase deficiency.
Immunodeficiency·1995
A syndrome involving immunodeficiency and multiple intestinal atresias.
Immunodeficiency·1995
Lymphoproliferative disorders and other tumors complicating immunodeficiencies.
Immunodeficiency·1994
Molecular basis of adenosine deaminase deficiency.
Immunodeficiency·1994
Novel HIV fusion-inhibitory lipopeptides exhibit dramatically improved activity against resistant mutants.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
Hydrophobic Tag Protein Degraders: An Emerging Therapeutic Strategy for Cancer.
Pharmaceuticals (Basel, Switzerland)·2026